Journal of Cancer Therapy

Vol.4 No.7(2013), Paper ID 36241, 7 pages

DOI:10.4236/jct.2013.47141

 

Treatment in Elderly Glioblastoma Patients: General Reduction of Standard Therapy Should Be Avoided. Prognostic Value of MGMT Is Questionable

 

Josef Pichler, Isolde Hoellmüller, Bahil Ghanim, Sabine Spiegl-Kreinecker

 

Department of Internal Medicine and Neurooncology, Landesnervenklinik, Linz, Austria
Department of Internal Medicine and Neurooncology, Landesnervenklinik, Linz, Austria
Medical University of Vienna, Vienna, Austria
Department of Internal Medicine and Neurooncology, Landesnervenklinik, Linz, Austria

 

Copyright © 2013 Josef Pichler, Isolde Hoellmüller, Bahil Ghanim, Sabine Spiegl-Kreinecker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


J. Pichler, I. Hoellmüller, B. Ghanim and S. Spiegl-Kreinecker, "Treatment in Elderly Glioblastoma Patients: General Reduction of Standard Therapy Should Be Avoided. Prognostic Value of MGMT Is Questionable," Journal of Cancer Therapy, Vol. 4 No. 7, 2013, pp. 1217-1223. doi: 10.4236/jct.2013.47141.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.